Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
European Journal of Clinical Pharmacology|May 17, 2008
How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approachKayode Ogungbenro, Leon Aarons
Journal of Biopharmaceutical Statistics|January 8, 2009
An effective approach for obtaining optimal sampling windows for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons
Journal of Biopharmaceutical Statistics|August 20, 2010
Sample size/power calculations for population pharmacodynamic experiments involving repeated-count measurementsKayode Ogungbenro, Leon Aarons
British Journal of Clinical Pharmacology|January 24, 2015
Physiologically based pharmacokinetic model for 6-mercpatopurine: exploring the role of genetic polymorphism in TPMT enzyme activityKayode Ogungbenro, Leon Aarons,
Basic & Clinical Pharmacology & Toxicology|January 28, 2010
Optimal design of pharmacokinetic studiesLeon Aarons, Kayode Ogungbenro
Journal of Biopharmaceutical Statistics|April 6, 2006
Sample size calculations based on generalized estimating equations for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons, Gordon Graham
Pharmaceutical Statistics|November 15, 2008
Application of optimal design methodologies in clinical pharmacology experimentsKayode Ogungbenro, Aristides Dokoumetzidis, Leon Aarons
The AAPS Journal|November 22, 2014
Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptyingKayode Ogungbenro, Henry Pertinez, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|August 2, 2015
Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokineticsThierry Wendling, Swati Dumitras, Kayode Ogungbenro, et al.
Pageof 17